BioFire Diagnostics is a startup based in the United States, 1 tracked investor.
Based in the United States, BioFire Diagnostics is a startup. Brouky records 1 investor associated with the company.
BioFire Diagnostics develops and provides the BIOFIRE System, a molecular diagnostic platform offering rapid, syndromic infectious disease testing through multiplex PCR assays that identify pathogens and antimicrobial resistance markers to aid healthcare providers and labs in faster and accurate diagnoses.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.